SPOTLIGHT -
Paris - Neurotech S.A. will exclusively develop and market Amgen Inc.'s ciliary neurotrophic factor (CNTF), a protein that has protective effects in animals with retinitis pigmentosa.
Bausch + Lomb announces results from a clinical study of a novel daily nutritional supplement for dry eyes
(EyePod) From idea to impact: Navigating ophthalmic innovation
The Fred Hollows Foundation supporting 2030 IN SIGHT LIVE
EyePod: Modifier Gene Therapy: What is it?
Verana Health launches its Qdata Thyroid Eye Disease module
Gene editing untangles one strand of the AMD web